Overview
- TickerWSTN on Nasdaq1
- IndustryServices-Offices & Clinics of Doctors of Medicine1
- HeadquartersE91
- Incorporated inCayman Islands3
- Business addressSuite 1165-L 3 Coleman Street #03-24, Singapore, 1798043
- Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
See how the biggest companies compare on our leaderboards
Placement Units”) to the Sponsor at a price of $10.00 per Private Placement Units, generating total gross proceeds of $2,350,000.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
Financial statements
Every line of the income statement as filed: the last 1 fiscal year, latest first.2
| Period ending | 2026-06-30 |
|---|---|
| Formation costs | $11.8K |
| Administrative fee | $478.6K |
| Total operating expenses | $490.3K |
| Income earned on marketable securities held in Trust Account | -$1.4M |
| Net income(loss) | $890.4K |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-10-31 | 2025-06-30 |
|---|---|---|---|
| Cash in bank | $319.0K | ||
| Deferred offering costs | $2.2M | $200.0K | |
| Total Current Assets | $319.0K | $200.0K | |
| Cash and marketable securities held in the trust | $58.9M | ||
| Total Assets | $59.2M | $200.0K | |
| Accrued expenses | $155.0K | ||
| Total Current Liabilities | $604.4K | $184.5K | |
| Deferred Underwriting Commission | $2.3M | ||
| Total Liabilities | $2.9M | $184.5K | |
| Class A ordinary shares, $0.0001 par value, 450,000,000 shares authorized, 5,750,000 shares subject to possible redemption as of June 30, 2026 | $54.4M | ||
| Additional paid-in capital | $978.6K | $24.8K | |
| Retained earnings/(Accumulated deficit) | $881.0K | -$9.5K | |
| Total Shareholders Equity | $1.9M | $15.5K | |
| Total Liabilities and Shareholders Equity | $59.2M | $200.0K |
| Period ending | 2026-06-30 | 2025-10-31 | 2025-06-30 |
|---|---|---|---|
| Cash in bank | $319.0K | ||
| Deferred offering costs | $2.2M | $200.0K | |
| Total Current Assets | $319.0K | $200.0K | |
| Cash and marketable securities held in the trust | $58.9M | ||
| Total Assets | $59.2M | $200.0K | |
| Accrued expenses | $155.0K | ||
| Total Current Liabilities | $604.4K | $184.5K | |
| Deferred Underwriting Commission | $2.3M | ||
| Total Liabilities | $2.9M | $184.5K | |
| Class A ordinary shares, $0.0001 par value, 450,000,000 shares authorized, 5,750,000 shares subject to possible redemption as of June 30, 2026 | $54.4M | ||
| Additional paid-in capital | $978.6K | $24.8K | |
| Retained earnings/(Accumulated deficit) | $881.0K | -$9.5K | |
| Total Shareholders Equity | $1.9M | $15.5K | |
| Total Liabilities and Shareholders Equity | $59.2M | $200.0K |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 1 fiscal year, latest first.2
| Period ending | 2026-06-30 |
|---|---|
| Net income | $890.4K |
| Income earned on marketable securities held in Trust Account | -$1.4M |
| Formation costs paid by Sponsor | $4.3K |
| Accrued expenses | $155.0K |
| Net cash used in operating activities | -$331.0K |
| Purchase of marketable securities held in Trust Account | -$57.5M |
| Net cash used in investing activity | -$57.5M |
| Proceeds from sale of public units through public offerings, net of underwriters discount | $57.5M |
| Proceeds from ordinary shares issued in private placement | $2.4M |
| Payment of offering costs | -$1.7M |
| Net cash provided by financing activities | $58.1M |
| Net change in cash | $319.0K |
| Deferred offering costs paid by Sponsor under the promissory note-related party | $260.6K |
| Accretion of ordinary shares subject to redemption value | $4.8M |
| Deferred underwriting commission accrued and offset against additional paid-in capital | $2.3M |
No quarter-by-quarter statement was filed.
Corporate structure
Westin Acquisition Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Westin Acquisition Corp
- WOLVERINE ASSET MANAGEMENT LLC Filed SCHEDULE 13G/A on Westin Acquisition Corp, latest Oct 6, 2026 (2 filings since Jul 14, 2026)
- Westin Investment Co. Ltd. Filed SCHEDULE 13D/A on Westin Acquisition Corp, latest Jul 28, 2026 (2 filings since Dec 12, 2025)
- Karpus Management, Inc. Filed SCHEDULE 13G/A on Westin Acquisition Corp, latest May 14, 2026 (2 filings since Mar 6, 2026)
- Shaolin Capital Management LLC Filed SCHEDULE 13G on Westin Acquisition Corp, latest Feb 17, 2026
- Feis Equities LLC Filed SCHEDULE 13G/A on Westin Acquisition Corp, latest Feb 4, 2026 (2 filings since Nov 12, 2025)
- Westin Acquisition Corp E9
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Westin Acquisition Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Properties, in its own words
We do not own any real estate or other physical properties materially important to our operations. We maintain our principal executive office at Suite 1165-L, 3 Coleman Street #03-24, Singapore 179804.
Item 2 of the 10-K filed Sep 29, 2026.4
Leadership
Who has led Westin Acquisition Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
- Chief executive officerKok Peng Na Dec 10, 2025 to now7
- ChairKok Peng Na Dec 10, 2025 to now7
- Chief financial officerStanney Patrick Majawit Dec 10, 2025 to now8
Board members and other officers (2)
- Board memberAdrian Xinglun Chung Dec 10, 2025 to now9
- Board memberKadir Nakoorsha Bin Abdul Dec 10, 2025 to now10
Timeline
- Jul 29, 20268-K Entered a material agreement; Change in control; Regulation FD disclosure11
- Dec 31, 20258-K Other events12
- Dec 23, 20258-K Other events13
- Dec 10, 2025New chief executive Kok Peng Na becomes CEO7
- Nov 12, 20258-K Other events14
- Nov 6, 20258-K Entered a material agreement; Unregistered sale of shares; Executive or director change15
Filings
41 filings to the SEC since October 2021: 1 annual reports, 5 quarterly reports, 5 major events, 6 insider forms, 9 large holders, 15 other. The latest 20:
- Oct 6, 2026SCHEDULE 13G/A EDGAR
- Sep 29, 202610-K ANNUAL REPORT EDGAR
- Sep 28, 202610-Q/A AMENDMENT NO. 1 TO FORM 10-Q EDGAR
- Sep 28, 202610-Q/A AMENDMENT NO. 1 TO FORM 10-Q EDGAR
- Jul 29, 2026425 CURRENT REPORT EDGAR
- Jul 29, 20268-K CURRENT REPORT EDGAR
- Jul 28, 2026SCHEDULE 13D/A EDGAR
- Jul 14, 2026SCHEDULE 13G EDGAR
- May 15, 202610-Q QUARTERLY REPORT EDGAR
- May 14, 2026SCHEDULE 13G/A EDGAR
- Mar 6, 2026SCHEDULE 13G EDGAR
- Feb 17, 2026SCHEDULE 13G EDGAR
- Feb 13, 202610-Q QUARTERLY REPORT EDGAR
- Feb 4, 2026SCHEDULE 13G/A EDGAR
- Jan 6, 202625-NSE EDGAR
- Dec 31, 20258-K CURRENT REPORT EDGAR
- Dec 30, 202525-NSE EDGAR
- Dec 23, 20258-K CURRENT REPORT EDGAR
- Dec 12, 2025SCHEDULE 13D EDGAR
- Dec 10, 20253 OWNERSHIP DOCUMENT EDGAR
The 41 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- WOLVERINE ASSET MANAGEMENT LLCSCHEDULE 13G/A, 2 filings Jul 14, 2026 to Oct 6, 202616
- Westin Investment Co. Ltd.SCHEDULE 13D/A, 2 filings Dec 12, 2025 to Jul 28, 202617
- Karpus Management, Inc.SCHEDULE 13G/A, 2 filings Mar 6, 2026 to May 14, 202618
- Shaolin Capital Management LLCSCHEDULE 13G, 1 filing Feb 17, 202619
- Feis Equities LLCSCHEDULE 13G/A, 2 filings Nov 12, 2025 to Feb 4, 202620
SEC filer profile
How Westin Acquisition Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARWestin Acquisition Corp1
- CIK0002076192
- Employer ID (EIN)00-00000004
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
- Incorporated inCayman Islands4
- Fiscal year endsJune 301
- Industry code (SIC)8011 Services-Offices & Clinics of Doctors of Medicine1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business addressSuite 1165-L 3 Coleman Street #03-24, Singapore, 179804, Singapore1
- Phone65 9488 44251
- Shares outstanding7,908,613 as of Sep 25, 20266
- Public float$0 as of Jun 30, 20262
- AuditorAudit Alliance LLP, Singapore PCAOB ID 3487; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceJul 23, 20251
- Filings41 in all: 3 (6), 8-K (5), SCHEDULE 13G (4), 10-Q (3), S-1/A (3), SCHEDULE 13G/A (3), 10-Q/A (2), 25-NSE (2)1
All 19 form types
CORRESP (2), UPLOAD (2), 10-K (1), 424B4 (1), 425 (1), 8-A12B (1), CERT (1), NT 10-Q (1), S-1 (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Sep 29, 2026
Quarterly report (10-Q) May 15, 2026
Latest 8-K (8-K) Jul 29, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Units, each consisting of one Class A Ordinary Share, par value $0.0001, and one Right entitling the holder to receive one-sixth (1/6) | WSTNU | Nasdaq |
| Class A Ordinary Shares, par value $0.0001 per share | WSTN | Nasdaq |
| Rights to receive one-sixth (1/6) of one Class A Ordinary Share | WSTNR | Nasdaq |
From the cover page of the 10-K filed Sep 29, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
Legal proceedings
We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARKok Peng Na, Chief executive officer
- 8
- 9SEC EDGARAdrian Xinglun Chung, Board member
- 10
- 11
- 12SEC EDGAROther events
- 13SEC EDGAROther events
- 14SEC EDGAROther events
- 15
- 16
- 17
- 18
- 19
- 20